Maryland Heights, MO, January 09, 2017 --(PR.com
)-- The global biopsy devices market is growing at the rate of 5.8% CAGR and estimated to reach USD 2.1 Billion by 2020, due to higher preference for minimal invasive technologies and rising geriatric population worldwide.
Visit Biopsy Devices Market – Product Types (Needle-Based Guns -Vacuum-Assisted, Core Needle, Fine Needle Aspiration; Biopsy Needles – Disposable, Reusable; Biopsy Forceps – Cold and Hot; Guidance Systems – Manual and Robotic) 2016-2020 at https://www.ihealthcareanalyst.com/report/biopsy-devices-market/
Biopsy procedure, either external or incisional, involves extraction of sample cells or tissues for examination to determine the presence or extent of a disease which is generally examined under a microscope or analyzed chemically. Appropriate biopsy methods depend upon a variety of factors, including the size, location, appearance and characteristics of the abnormality. Biopsy devices are gaining importance due to the increasing incidence of cancer globally and the growing willingness of patients to spend money on these medical procedures. Biopsies are usually performed to identify and diagnose cancerous tumor and to design a suitable treatment plan for the patients. Biopsies are performed using image-guidance modalities such as X-ray imaging, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound imaging. Biopsy devices make use of three main types of needle-based technologies to withdraw samples, namely, vacuum-assisted, core needle and fine needle aspiration. These procedures can be performed using manually guided systems as well as robotic systems.
The global biopsy devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on product type (needle-based guns -vacuum-assisted, core needle, fine needle aspiration; biopsy needles – disposable, reusable; biopsy forceps – cold and hot; guidance systems – manual and robotic), and forecasts growth trends (CAGR% - 2016 to 2020).
The global biopsy devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global biopsy devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global biopsy devices market and included in this report are Angiotech, C R Bard Inc., CareFusion Corporation, Devicor Medical Products Inc. and Hologic Inc.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043